-
1
-
-
0035145552
-
Fluorouracil and the new oral fluorinated pyrimidines
-
Kuhn JG. Fluorouracil and the new oral fluorinated pyrimidines. Ann Pharmacother 2001;35:217-227 (Pubitemid 32127133)
-
(2001)
Annals of Pharmacotherapy
, vol.35
, Issue.2
, pp. 217-227
-
-
Kuhn, J.G.1
-
2
-
-
19944430939
-
Combination of IFN-α and 5-fluorouracil induces apoptosis through IFN-α/β receptor in human hepatocellular carcinoma cells
-
Kondo M, Nagano H, Wada H, et al. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells. Clin Cancer Res 2005;11:1277-1286 (Pubitemid 40175781)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.3
, pp. 1277-1286
-
-
Kondo, M.1
Nagano, H.2
Wada, H.3
Damdinsuren, B.4
Yamamoto, H.5
Hiraoka, N.6
Eguchi, H.7
Miyamoto, A.8
Yamamoto, T.9
Ota, H.10
Nakamura, M.11
Marubashi, S.12
Dono, K.13
Umeshita, K.14
Nakamori, S.15
Sakon, M.16
Monden, M.17
-
3
-
-
33947577494
-
The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha
-
Oie S, Ono M, Yano H, et al. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha. Int J Oncol 2006;29:1469-1478
-
(2006)
Int J Oncol
, vol.29
, pp. 1469-1478
-
-
Oie, S.1
Ono, M.2
Yano, H.3
-
4
-
-
34548091012
-
Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells
-
DOI 10.1158/1535-7163.MCT-06-0281
-
Oie S, Ono M, Fukushima H, et al. Alteration of dihydropyrimidine dehydrogenase expression by IFN-alpha affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells. Mol Cancer Ther 2007;6:2310-2318 (Pubitemid 47294759)
-
(2007)
Molecular Cancer Therapeutics
, vol.6
, Issue.8
, pp. 2310-2318
-
-
Oie, S.1
Ono, M.2
Fukushima, H.3
Hosoi, F.4
Yano, H.5
Maruyama, Y.6
Kojiro, M.7
Terada, T.8
Hirano, K.9
Kuwano, M.10
Yamada, Y.11
-
5
-
-
0034048729
-
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
-
Salonga D, Danenberg KD, Johnson M, et al. Colorectal tumors responding to 5- fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 2000;6:1322-1327 (Pubitemid 30226214)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.4
, pp. 1322-1327
-
-
Salonga, D.1
Danenberg, K.D.2
Johnson, M.3
Metzger, R.4
Groshen, S.5
Tsao-Wei, D.D.6
Lenz, H.-J.7
Leichman, C.G.8
Leichman, L.9
Diasio, R.B.10
Danenberg, P.V.11
-
6
-
-
0034234872
-
DUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: Association with survival and response to 5-fluorouracil in colorectal cancer
-
Ladner RD, Lynch FJ, Groshen S, etal. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5- fluorouracil in colorectal cancer. Cancer Res 2000; 60:3493-3503 Pubitemid 30482169)
-
(2000)
Cancer Research
, vol.60
, pp. 3493-3503
-
-
Ladner, R.D.1
Lynch, F.J.2
Groshen, S.3
Xiong, Y.P.4
Sherrod, A.5
Caradonna, S.J.6
Stoehlmacher, J.7
Lenz, H.-J.8
-
7
-
-
0028006858
-
Population study of dihydropyrimidine dehydrogenase in cancer patients
-
Etienne MC, Lagrange JL, Dassonville 0, et al. Population study of dihydropyrimidine dehydrogenase in cancer patients. J Clin Oncol 1994;12:2248-2253
-
(1994)
J Clin Oncol
, vol.12
, pp. 2248-2253
-
-
Etienne, M.C.1
Lagrange, J.L.2
Dassonville, O.3
-
8
-
-
1942453306
-
Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil
-
DOI 10.1016/j.ejca.2003.12.004, PII S0959804903010694
-
van Kuilenburg ABP. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. Eur J Cancer 2004;40:939-950 (Pubitemid 38496249)
-
(2004)
European Journal of Cancer
, vol.40
, Issue.7
, pp. 939-950
-
-
Van Kuilenburg, A.B.P.1
-
9
-
-
0032143631
-
Characterization of the human dihydropyrimidine dehydrogenase gene
-
DOI 10.1006/geno.1998.5379
-
Wei X, Elizondo G, Sapone A, et al. Characterization of the human dihydropyrimidine dehydrogenase gene. Genomics 1998;51:391-400. (Pubitemid 28413205)
-
(1998)
Genomics
, vol.51
, Issue.3
, pp. 391-400
-
-
Wei, X.1
Elizondo, G.2
Sapone, A.3
McLeod, H.L.4
Raunio, H.5
Fernandez-Salguero, P.6
Gonzalez, F.J.7
-
10
-
-
0032812092
-
Dihydropyrimidine dehydrogenase activity: Prognostic partner of 5- fluorouracil?
-
Allegra CJ. Dihydropyrimidine dehydrogenase activity: prognostic partner of 5- fluorouracil? Clin Cancer Res 1999;5:1947-1949 (Pubitemid 29399242)
-
(1999)
Clinical Cancer Research
, vol.5
, Issue.8
, pp. 1947-1949
-
-
Allegra, C.J.1
-
11
-
-
0034901306
-
Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: Frequency of the common IVS14+1G>A mutation causing DPD deficiency
-
van Kuilenburg ABP, Muller EW, Haasjes J, et al. Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G.A mutation causing DPD deficiency. Clin Cancer Res 2001;7:1149-1153 (Pubitemid 32708664)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.5
, pp. 1149-1153
-
-
Van Kuilenburg, A.B.P.1
Muller, E.W.2
Haasjes, J.3
Meinsma, R.4
Zoetekouw, L.5
Waterham, H.R.6
Baas, F.7
Richel, D.J.8
Van Gennip, A.H.9
-
12
-
-
33947715687
-
Changes to the dihydropyrimidine dehydrogenase gene copy number influence the susceptibility of cancers to 5-FU-based drugs: Data mining of the NCI-DTP data sets and validation with human tumour xenografts
-
DOI 10.1016/j.ejca.2006.09.026, PII S0959804906010665
-
Kobunai T, Ooyama A, Sasaki S, et al. Changes to the dihyfropyrimidine dehydrogenase gene copy number influence the susceptibility of cancers to 5-FU- based drugs: Data mining of the NCI-DTP data sets and validation with human tumor xenografts. Eur J Cancer 2007;43:791-798 (Pubitemid 46505001)
-
(2007)
European Journal of Cancer
, vol.43
, Issue.4
, pp. 791-798
-
-
Kobunai, T.1
Ooyama, A.2
Sasaki, S.3
Wierzba, K.4
Takechi, T.5
Fukushima, M.6
Watanabe, T.7
Nagawa, H.8
-
13
-
-
0032763166
-
Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours
-
Fleischmann J, Kremmer E, Muller S, et al. Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours. Int J Cancer 1999;84:614-617
-
(1999)
Int J Cancer
, vol.84
, pp. 614-617
-
-
Fleischmann, J.1
Kremmer, E.2
Müller, S.3
-
14
-
-
33748499794
-
Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1
-
DOI 10.1002/ijc.22080
-
Ichikawa W, Takahashi T, Suto K, et al. Simple combination of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1. Int J Cancer 2006;119:1927-1933 (Pubitemid 44356853)
-
(2006)
International Journal of Cancer
, vol.119
, Issue.8
, pp. 1927-1933
-
-
Ichikawa, W.1
Takahashi, T.2
Suto, K.3
Shirota, Y.4
Nihei, Z.5
Shimizu, M.6
Sasaki, Y.7
Hirayama, R.8
-
15
-
-
33745643340
-
Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy
-
DOI 10.1002/jso.20553
-
Ochiai T, Nishimura K, Noguchi H, et al. Prognostic impact of orotate phosphoribosyl transferase activity in resectab e co orecta cancers treated by 5-f uorouraci -based adjuvant chemotherapy. J Surg Oncol 2006;94:45-50. (Pubitemid 43967722)
-
(2006)
Journal of Surgical Oncology
, vol.94
, Issue.1
, pp. 45-50
-
-
Ochiai, T.1
Nishimura, K.2
Noguchi, H.3
Kitajima, M.4
Tsuruoka, Y.5
Takahashi, Y.6
Tsukada, A.7
Watanabe, E.8
Nagaoka, I.9
Futagawa, S.10
|